Carisma Therapeutics Inc. (NASDAQ: CARM) stock closed at 3.1 per share at the end of the most recent trading day (a -0.3% change compared to the prior day closing price) with a volume of 5.35K shares and market capitalization of 130.43M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Carisma Therapeutics Inc. CEO is Steven Kelly.

The one-year performance of Carisma Therapeutics Inc. stock is %, while year-to-date (YTD) performance is -37.48%. CARM stock has a five-year performance of -63.71%. Its 52-week range is between 3.22 and 19.3, which gives CARM stock a 52-week price range ratio of 0.13%

Carisma Therapeutics Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -%, a ROC of -% and a ROE of -%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $- revenue per share.

Of the last four earnings reports from Carisma Therapeutics Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Carisma Therapeutics Inc.’s next earnings report date is 08th May 2023.

The consensus rating of Wall Street analysts for Carisma Therapeutics Inc. is Hold (3), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Carisma Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Carisma Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Carisma Therapeutics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.50, ATR14 : 0.52, CCI20 : -219.89, Chaikin Money Flow : -0.03, MACD : 0.18, Money Flow Index : 57.51, ROC : -33.68, RSI : 27.77, STOCH (14,3) : 9.70, UO : 34.86, Williams %R : -90.30), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Carisma Therapeutics Inc. in the last 12-months were: Elly Ryu (Sold 7 159 shares of value $4 204 ), Glen C. MacDonald (Sold 25 927 shares of value $15 227 ), Mark R. Sullivan (Sold 39 831 shares of value $23 393 ), Monica Forbes (Sold 61 862 shares of value $36 332 ), Thomas R. Cannell (Sold 53 727 shares of value $31 554 )